We have today published the 2022/23 annual report for Community Pharmacy England, reflecting on our work in the past year on behalf of all pharmacy owners. This has been an incredibly challenging year for the community pharmacy sector, and we continue to fight hard to improve the outlook on both funding and operational pressures. The
Read moreFollowing discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (29/09/2023) announced the following final list of price concessions for September 2023: Drug Pack size Price concession Atorvastatin 80mg tablets 28 £5.32 Brimonidine 0.2% eye drops 5 £3.20
Read moreThe Department of Health and Social Care (DHSC) has confirmed that sufficient stock of Utrogestan® 100mg capsules are now available to meet normal demand. As a result the Serious Shortage Protocol (SSP), SSP056 Utrogestan® 100mg capsules expires at 23.59pm on Friday 29 September 2023. After this date, any prescriptions for Utrogestan® 100mg capsules must be dispensed
Read moreCommunity Pharmacy England met in London for a full Committee Meeting on 13th and 14th September 2023. Committee Members spent time considering a response to the Government on the Primary Care Access Recovery Plan negotiations and laying the groundwork for the next Community Pharmacy Contractual Framework (CPCF) negotiations, informed by sector polling. The packed two-day
Read moreFollowing the recommendations made by the Independent Medicines and Medical Devices Safety Review and the outcome of a recent public consultation on Original pack dispensing and supply of medicines containing sodium valproate, changes to Human Medicines Regulations 2023 come into effect on the 11th October that mandate full pack dispensing of all licensed medicines containing valproate (see exemption
Read moreDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for Azelaic acid (Skinoren®) 20% cream. MSN/2023/090 Tier 2 – medium impact Date of issue 27th September 2023 Azelaic acid (Skinoren®) 20% cream is out of stock until early November 2023. Azelaic acid (Finacea®) 15% gel remains available but cannot support an
Read moreDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for Disopyramide (Rythmodan®)100mg capsules. MSN/2023/091 Tier 2 – medium impact Date of issue 27th September 2023 Disopyramide (Rythmodan®)100mg capsules are out of stock until late October 2023. Disopyramide (Rythmodan®) 250mg prolonged release tablets are out of stock until mid-December 2023 but parallel
Read moreClass 4 Medicines Defect Information: Max Healthcare Paracetamol 500 mg Capsules (Max Remedies Ltd) Drug alert number:EL (23)A/37 Date issued: 27 September 2023 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Max Healthcare Paracetamol 500 mg Capsules (Max Remedies Ltd) Company name: Max Remedies Ltd
Read moreFollowing discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (27/09/2023) announced the following list of price concessions for September 2023: Drug Pack size Price concession Atomoxetine 10mg capsules 28 £44.45 Atomoxetine 18mg capsules 28 £42.95 Atomoxetine 25mg
Read moreNational Patient Safety Alert: Shortage of methylphenidate prolonged-release capsules and tablets, lisdexamfetamine capsules, and guanfacine prolonged-release tablets. National Patient Safety Alert Reference Number: NatPSA/2023/011/DHSC Date issued: 27th September 2023 Brief description of the problem There are supply disruptions affecting various strengths of the following medications which are licensed for the treatment of attention deficit hyperactivity
Read more
